Generalized substitution of isoencoding codons shortens the duration of papillomavirus L1 protein expression in transiently gene-transfected keratinocytes due to cell differentiation

Nucleic Acids Research

Volumn 35, Issue 14, 2007, Pages 4820-4832

  Gu, Wenyi ^a   Ding, Jianmin ^a   Wang, Xiao ^a   de Kluyver, Rachel L ^a   Saunders, Nicholas A ^a   Frazer, Ian H ^a   Zhao, Kong Nan ^a  

^a UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; MYC PROTEIN; PAPILLOMA VIRUS L1 PROTEIN; PLASMID DNA; PROTEIN E7; PROTEIN FOS; TRANSFER RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CODON USAGE; CONTROLLED STUDY; DOWN REGULATION; GENE EXPRESSION; GENE THERAPY; GENETIC TRANSFECTION; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; KERATINOCYTE; NONHUMAN; PAPILLOMA VIRUS; PATTERN RECOGNITION; PLASMID; POSTTRANSCRIPTIONAL GENE SILENCING; PRIORITY JOURNAL; PROTEIN SYNTHESIS; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; TRANSGENE; TRANSLATION REGULATION; UPREGULATION; VIRUS CAPSID; WESTERN BLOTTING;

ANIMALS; CAPSID PROTEINS; CELL DIFFERENTIATION; CELL-FREE SYSTEM; CELLS, CULTURED; CODON; GENE EXPRESSION REGULATION, VIRAL; HUMANS; KERATINOCYTES; KINETICS; MICE; ONCOGENE PROTEINS, VIRAL; PROTEIN BIOSYNTHESIS; RNA, TRANSFER; TRANSCRIPTION, GENETIC; TRANSFECTION;

PAPILLOMAVIRIDAE;

EID: 34547857749     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkm496     Document Type: Article

References (68)

1. Lloyd,A.T. and Sharp,P.M. (1992) Evolution of codon usage patterns: The extent and nature of divergence between Candida albicans and Saccharomyces cerevisiae. Nucleic Acids Res., 20, 5289-5295.
2. Grantham,R., Gautier,C. and Gouy.M. (1980) Codon frequencies in 119 individual genes confirm consistent choices of degenerate bases according to genome type. Nucleic Acids Res., 8, 1893-1912.
3. Grantham,R., Gautier,C., Gouy,M., Mercier,R. and Pave,A. (1980) Codon catalog usage and the genome hypothesis. Nucleic Acids Res., 8 r49-r62.
4. Kanaya,S., Yamada,Y., Kudo,Y. and Ikemura.T. (1999) Studies of codon usage and tRNA genes of 18 unicellular organisms and quantification of Bacillus subtilis tRNAs: Gene expression level and species-specific diversity of codon usage based on multivariate analysis. Gene, 238, 143-155.
5. Bennetzen,J.L. and Hall,B.D. (1982) Codon selection in yeast. J. Biol. Chem., 257, 3026-3031.
6. Gouy,M. and Ga.utier,C. (1982) Codon usage in bacteria: Correlation with gene expressivity. Nucleic. Acids Res., 10, 7055-7074.
7. Plotkin,J.B., Robins,H. and Levine,A.J. (2004) Tissue-specific codon usage and the expression of human genes. Proc. Natl Acad. Sci. USA.
8. Sanchez,G., Bosch,A. and Pinto,R.M. (2003) Genome variability and capsid structural constraints of hepatitis a virus. J. Virol., 77, 452-459.
9. Jenkins,G.M., Pagel,M., Gould,E.A., de,A.Z.P.M. and Holmes,E.C. (2001) Evolution of base composition and codon usage bias in the genus Flavivirus. J. Mol. Evol., 52, 383-390.
10. Zhou,J., Liu,W.J., Peng,S.W., Sun,X.Y. and Frazer,I. (1999) Papillomavirus capsid protein expression level depends on the match between codon usage and tRNA availability. J. Virol., 73, 4972-4982.
11. Zhao,K.N., Liu,W.J. and Frazer,I.H. (2003) Codon usage bias and A + T content variation in human papillomavirus genomes. Virus Res., 98, 95-104.
12. Frattini,M.G., Lim,H.B. and Laimins,L.A. (1996) In vitro synthesis of oncogenic human papillomaviruses requires episomal genomes for differentiation-dependent late expression. Proc. Natl Acad. Sci. USA 93, 3062-3067.
13. Cumming,S.A., Repellin,C.E., McPhillips,M., Radford,J.C., Clements,J.B. and Graham,S.V. (2002) The human papillomavirus type 31 late 3′ untranslated region contains a complex bipartite negative regulatory element. J. Virol., 76, 5993-6003.
14. Leder,C., Kleinschmidt,J.A., Wiethe,C., Muller,M., Thomas,R. and Frazer,I.H. (2001) Enhancement of capsid gene expression: Preparing the human papillomavirus type 16 major structural gene L1 for DNA vaccination purposes. J. Virol., 75, 9201-9209.
15. Liu,W.J., Zhao,K.N., Gao,F.G., Leggatt,G.R., Fernando,G.J., Thomas,R. and Frazxer,I.H. (2001) Polynucleotide viral vaccines: Codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. Vaccine, 20, 862-869.
16. Liu,W.J., Gao,F., Zhao,K.N., Zhao,W., Fernando,G.J. and Frazer,I.H. (2002) Codon modified human papillomavirus type 16 E7 DNA vaccine enhances cytotoxic T-lymphocyte induction and anti-tumout activity. Virology, 301, 43-52.
17. Gu,W., Li,M., Zhao,W.M., Fang,NX, Bu,S., Frazer,I.H. and Zhao,K.N. (2004) tRNASer(CGA) differentially regulates expression of wild-type and codon-modified papillomavirus L1 genes. Nucleic Acids Res., 32 4448-4461.
18. Haas,J., Park,E.C. and Seed,B. (1996) Codon usage limitation in the expression of HIV-1 envelope glycoprotein. Curr. Biol., 6, 315-324.
19. Kofman,A., Graf,M., Deml,L., Wolf,H. and Wagner,R. (2003) Codon usage-mediated inhibition of HIV-1 gag expression in mammalian cells occurs independently of translation. Tsitologiia, 45, 94-100.
20. zur Megede,J., Chen,M.C., Doe,B., Schaefer,M., Greer,C.E., Selby,M., Otten,G.R. and Barnett,S.W. (2000) Increased expression and immunogenicity of sequence-modified human immunodeficiency virus type 1 gag gene. J. Virol., 74, 2628-2635.
21. Heim,R., Cubitt,A.B. and Tsien,R.Y. (1995) Improved green fluorescence. Nature, 373, 663-664.
22. Kong,W., Tian,C., Liu,B. and Yu,X.F. (2002) Stable expression of primary human immunodeficiency virus type 1 structural gene products by use of a noncytopathic sindbis virus vector. J. Virol., 76, 11434-11439.
23. Zhao,K.N., Gu,W., Fang,N.X., Saunders,N.A. and Frazer,I.H. (2005) Gene codon composition determines differentiation-dependent expression of a viral capsid gene in keratinocytes in vitro and in vivo. Mol. Cell Biol., 25, 8643-8655.
24. Maniura-Weber,K., Goffart,S., Garstka,H.L., Montoya,J. and Wiesner,R.J. (2004) Transient overexpression of mitochondrial transcription factor A (TFAM) is sufficient to stimulate mitochondrial DNA transcription, but not sufficient to increase mtDNA copy number in cultured cells. Nucleic Acids Res., 32, 6015-6027.
25. Koterba,K.L. and Rowan,B.G. (2006) Measuring ligand-dependent and ligand-independent interactions between nuclear receptors and associated proteins using Bioluminescence Resonance Energy Transfer (BRET). Nucl. Recept. Signal, 4, e021.
26. Zhao,K.N., Tomlinson,L., Liu,W.J., Gu,W. and Frazer,I.H. (2003) Effects of additional sequences directly downstream from the AUG on the expression of GFP gene. Biochim. Biophys. Acta, 1630, 84-95.
27. Saunders,N., Dicker,A., Popa,C., Jones,S. and Dahler,A. (1999) Histone deacetylase inhibitors as potential anti-skin cancer agents. Cancer Res., 59, 399-404.
28. Liu,W.J., Zhao,K.N., Gao,F.G., Leggatt,G.R., Fernando,G.J. and Frazer,I.H. (2001) Polynucleotide viral vaccines: Codon optimisation and ubiquitin conjugation enhances prophylactic and therapeutic efficacy. Vaccine, 20, 862-869.
29. Zhao,K.N. and Frazer,I.H. (20021 Saccharomyces cerevisiae is permissive for-replication of bovine papillomavirus type 1. J. Virol., 76 12265-12273.
30. Favre,D., Berthillon,P. and Trepo,C. (2001) Removal of cell-bound lipoproteins: A crucial step for the efficient infection of liver cells with hepatitis C virus in vitro. C. R. Acad Sci. III, 324, 1141-1148.
31. Pelham,H.R. and Jackson,R.J. (1976) An efficient mRNA-dependent translation system from reticulocyte lysates. Eur. J. Biochem., 67, 247-256.
32. Li,E.R., Owens,D.M., Djian,P, and Watt,F.M. (2000) Expression of involucrin in normal, hyperprotiferative and neoplastic mouse keratinocytes. Exp. Dermatol., 9, 431-438.
33. Simon,M. and Green,H. (1985) Enzymatic cross-linking of involucrin and other proteins by keratinocyte particulates in vitro. Cell, 40 677-683.
34. Furth,P.A. and Baker,C.C. (1991) An element in the bovine papillomavirus late 3′ untranslated region reduces polyadenylated cytoplasmic RNA levels. J. Virol., 65, 5806-5812.
35. Zeltner,R., Borenstein,L.A., Wettstein,F.O. and Iftner,T. (1994) Changes in RNA expression pattern during the malignant progression of cottontail rabbit papillomavirus-induced tumors in rabbits. J. Virol., 68 3620-3630.
36. Ozbun,M.A. and Meyers,C. (1997) Characterization of late gene transcripts expressed during vegetative replication of human papillomavirus type 31b. J. Virol., 71, 5161-5172.
37. Cumming,S.A., McPhillips,M.G., Veerapraditsin,T., Milligan,S.G. and Graham,S.V. (2003) Activity of the human papillomavirus type 16 late negative regulatory element is partly due to four weak consensus 5′ splice sites that bind a U1 snRNP-like complex. J. Virol., 77 5167-5177.
38. Doorbar,J., Parton,A., Hartley,K., Banks,L., Crook,T., Stanley,M. and Crawford,L. (1990) Detection of novel splicing patterns in a BPV16-containing keratinocyte cell line. Virology, 178, 254-262.
39. Stoler,M.H., Rhodes,C.R., Whitbeck,A., Wolinsky,S.M., Chow,L.T. and Broker,T.R. (1992). Human papillomavirus type 16 and 18 gene expression in cervical neoplasias. Hum. Pathol., 23, 117-128.
40. Zhao,C., Tan,W., Sokolowski,M. and Schwartz,S. (1996) Identification of nuclear and cytoplasmic proteins that interact specifically with an AU-rich, cis-acting inhibitory sequence in the 3′ untranslated region of human papillomavirus type 1 late mRNAs. J. Virol., 70, 3659-3667.
41. Zhao,X., Rush,M., Carlsson,A. and Schwartz,S. (2007) The presence of inhibitory RNA elements in the late 3_p,-untranslated region is a conserved property of human papillomaviruses. Virus Res., 125 135-144.
42. Sasagawa,T., Pushko,P., Steers,G., Gschmeissner,S.E., Hajibagheri,M.A., Finch,J., Crawford,L. and Tommasino,M. (1995) Synthesis and assembly of virus-like particles of human papillomaviruses type 6 and type 16 in fission yeast Schizosaccharomyces pombe. Virology, 206, 126-135.
43. Jansen,K.U., Rosolowsky,M., Schultz,L.D., Markus,H.Z., Cook,J.C., Donnelly,J.J., Martinez,D., Ellis,R.W. and Shaw,A.R. (1995) Vaccination with yeast-expressed cottontail rabbit papillomavirus (CRPV) virus-like particles protects rabbits from CRPV-induced papilloma formation. Vaccine, 13, 1509-1514.
44. Rush,M., Zhao,X. and Schwartz,S. (2005) A splicing enhancer in the E4 coding region of human papillomavirus type 16 is required for early mRNA splicing and polyadenylation as well as inhibition of premature late gene expression. J. Virol., 79, 12002-12015.
45. Zhao,X., Oberg,D., Rush,M., Fay,J., Lambkin,H. and Schwartz,S. (2005) A 57-nucleotide upstream early polyadenylation element in human papillomavirus type 16 interacts with hFip1, CstF-64, hnRNP C1/C2, and polypyrimidine tract binding protein. J. Virol., 79, 4270-4288.
46. Tan,T.M. and Ting,R.C. (1995) In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes. Cancer Res., 55, 4599-4605.
47. Collier,B., Oberg,D., Zhao,X. and Schwartz,S. (2002) Specific inactivation of inhibitory sequences in the 5′ end of the human papillomavirus type 16 L1 open reading frame results in production of high levels of L1 protein in human epithelial cells. J. Virol., 76, 2739-2752.
48. Dover,R. and Potten,C.S. (1983) Cell cycle kinetics of cultured human epidermal keratinocytes. J. Invest. Dermatol., 80, 423-429.
49. Banks-Schlegel,S. and Green,H. (1981) Involucrin synthesis and tissue assembly by keratinocytes in natural and cultured human epithelia. J. Cell. Biol., 90, 732-737.
50. Cid-Arregui,A., Juarez,V. and zur Hausen,H. (2003) A synthetic E7 gene of human papillomavirus type 16 that yields enhanced expression of the protein in mammalian cells and is useful for DNA immunization studies. J. Virol., 77, 4928-4937.
51. Dotto,G.P., Gilman,M.Z., Maruyama,M. and Weinberg,R.A. (1986) c-myc and c-fos expression in differentiating mouse primary keratinocytes. EMBO J., 5, 2853-2857.
52. Chao,Y.C., Lee,S.T., Chang,M.C., Chen,H.H., Chen,S.S., Wu,T.Y., Liu,F.H., Hsu,E.L. and Hou,R.F. (1998) A 2.9-kilobase noncoding nuclear RNA functions in the establishment of persistent Hz-1 viral infection. J. Virol., 72, 2233-2245.
53. Bartlett,J.S., Sethna,M., Ramamurthy,L., Gowen,S.A., Samulski,R.J. and Marzluff,W.F. (1996) Efficient expression of protein coding genes from the murine U1 small nuclear RNA promoters. Proc. Natl Acad. Sci. USA 93, 8852-8857.
54. Karlin,S., Blaisdell,B.E. and Schachtel,G.A. (1990) Contrasts in codon usage of latent versus productive genes of Epstein-Barr virus: Data and hypotheses. J. Virol., 64, 4264-4273.
55. Pavesi,A. (1999) Relationships between transcriptional and translational control of gene expression in Saccharomyces cerevisiae: A multiple regression analysis. J. Mol. Evol., 48, 133-141.
56. Levine,M. and Tjian,R. (2003) Transcription regulation and animal diversity. Nature, 424, 147-151.
57. Ostareck-Lederer,A., Ostareck,D.H., Cans,C., Neubauer,G., Bomsztyk,K., Superti-Furga,G. and Hentze,M.W. (2002) c-Src-mediated phosphorylation of hnRNP K drives translational activation of specifically silenced mRNAs. Mol. Cell Biol., 22, 4535-4543.
58. Ostareck,D.H., Ostareck-Lederer,A., Wilm,M., Thiele,B.J., Mann,M. and Hentze,M.W. (1997) mRNA silencing in erythroid differentiation: HnRNP K and hnRNP El regulate 15-lipoxygenase translation from the 3′ end. Cell, 89, 597-606.
59. Meier,J.L. and Pruessner,J.A. (2000) The human cytomegalovirus major immediate-early distal enhancer region is required for efficient viral replication and immediate-early gene expression. J. Virol., 74 1602-1613.
60. Hummel,M., Lim,H.B. and Laimins,L.A. (1995) Human papillomavirus type 31b late gene expression is regulated through protein kinase C-mediated changes in RNA processing. J. Virol., 69, 3381-3388.
61. Collier,B., Goobar-Larsson,L., Sokolowski,M. and Schwartz,S. (1998) Translational inhibition in vitro of human papillomavirus type 16 L2 mRNA mediated through interaction with heterogenous ribonucleoprotein K and poly(rC)-binding proteins 1 and 2. J. Biol. Chem., 273, 22648-22656.
62. Bulmer,M. (1987) Coevolution of codon usage and transfer RNA abundance. Nature, 325, 728-730.
63. Charles,H., Calevro,F., Vinuelas,J., Fayard,J.M. and Rahbe,Y. (2006) Codon usage bias and tRNA over-expression in Buchnera aphidicola after aromatic amino acid nutritional stress on its host Acyrthosiphon pisum. Nucleic Acids Res., 34, 4583-4592.
64. Duret,L. (2000) tRNA gene number and codon usage in the C. elegans genome are co-adapted for optimal translation of highly expressed genes. Trends Genet., 16, 287-289.
65. Moriyama,E.N. and Powell,J.R. (1997) Codon usage bias and tRNA abundance in Drosophila. J. Mol. Evol., 45, 514-523.
66. Mazzacano,C.A., Du,X. and Thiem,S.M. (1999) Global protein synthesis shutdown in Autographa californica nucleopolyhedrovirus-infected Ld652Y cells is rescued by tRNA from uninfected cells. Virology, 260 222-231.
67. Imamura,H., Jeon,B., Wakagi,T. and Matsuzawa,H. (1999) High level expression of Thermococcus litoralis 4-alpha-glucanotransferase in a soluble form in Escherichia coli with a novel expression system involving minor arginine tRNAs and GroELS. FEBS Lett., 457, 393-396.
68. Chen,G.F. and Inouye,M. (1990) Suppression of the negative effect of minor arginine codons on gene expression; preferential usage of minor codons within the first 25 codons of the Escherichia coli genes. Nucleic Acids Res., 18, 1465-1473.